Skip to content

Schering-Plough SGP Common Stock

Common Stock at other companies

Glaukos logo
GlaukosGKOS
$58K+1.8%
AbbVie logo
AbbVieABBV
$18M0.0%
Bausch + Lomb logo
Bausch + LombBLCO
$0
HRO
HarrowHROW
50M0.0%
EyePoint, Inc.
 logo
EyePoint, Inc. EYPT
$83K+20.3%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
$22K+37.5%

Other financials

Income statement

See full
Operating income-$15.4M-108%
Net income-$13.8M-56.6%
EPS (diluted)-$0.69+82.6%

Balance sheet

See full
Cash & equivalents$238.9M+312%
Total debt$1.6M
Total equity$250.1M+463%
Total assets$258.4M

Cash flow

See full
Operating cash flow-$13.5M-65.2%
CapEx$676.0K+312%
Free cash flow-$14.2M-70.0%

Valuation

See full
Market cap$744.23M-23.4%
Enterprise value$506.93M

Returns & leverage

See full
Return on equity-34.3%
Debt / equity
Current ratio38×

Where this comes from

Reported directly by Schering-Plough in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Schering-Plough’s 10-K, filed March 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Schering-Plough's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Schering-Plough's common stock?
Schering-Plough (SGP) reported common stock of 154.4M in Q4 2025.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).